Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Amryt pharma plc crawled time : 12:30 save search
Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented at IUIS
Published: 2023-11-16 (Crawled : 12:30) - biospace.com/
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma trial
Amryt Announces Successful Bioavailability Study for Mycapssa® (octreotide capsules)
Published: 2022-03-08 (Crawled : 12:30) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 0.0%
H: 3.69%
C: 0.31%
mycapssa ces success
Amryt Supports Rare Disease Day 2022
Published: 2022-02-25 (Crawled : 12:30) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 2.23%
H: 0.0%
C: 0.0%
day rare disease
Amryt to Report FY and Q4 2021 Results on March 9, 2022
Published: 2022-02-23 (Crawled : 12:30) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 0.0%
H: 1.8%
C: -5.11%
report results
Amryt Completes $125 Million Non-Dilutive Debt Refinancing
Published: 2022-02-22 (Crawled : 12:30) - globenewswire.com
MC | $53.99 -1.12% 0.0% 840K
|
Finance
|
| O: -0.86%
H: 0.88%
C: -0.97%
ARES S | $135.95 -0.4% -0.7% 1.1M
|
Finance
|
| O: -1.33%
H: 1.07%
C: -0.54%
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -1.44%
H: 0.75%
C: -3.26%
Amryt Announces Oleogel-S10 EMA Regulatory Update
Published: 2022-01-28 (Crawled : 12:30) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -3.2%
H: 2.52%
C: -2.43%
ema ces leo oleogel-s10
Amryt Announces New Patents for Oleogel-S10
Published: 2022-01-18 (Crawled : 12:30) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: -0.4%
H: 0.0%
C: -0.58%
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 5.28%
H: 0.57%
C: -5.97%
leo patent oleogel-s10
The Lancet Diabetes & Endocrinology Publishes Positive Results for the MPOWERED Phase 3 Trial for Mycapssa® (oral octreotide) in Acromegaly Patients
Published: 2022-01-04 (Crawled : 12:30) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
mycapssa trial diabetes positive results positive results phase 3 lancet
Aerie Pharmaceuticals Appoints Raj Kannan as Chief Executive Officer
Published: 2021-12-16 (Crawled : 12:30) - biospace.com/
KNSA | $17.85 0.96% 0.95% 370K
|
Health Technology
|
| O: 9.41%
H: 1.89%
C: -1.51%
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 1.98%
H: 1.23%
C: 0.41%
AERI | $15.25 0.0%
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: -6.45%
als
Amryt Provides Update on Regulatory Review Process for Oleogel-S10
Published: 2021-11-23 (Crawled : 12:30) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -9.58%
H: 3.4%
C: 0.7%
leo oleogel-s10 filsuvez pdufa
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.